Vaccine trial finds a glitch with children in one age range
Enlarge (credit: Reshi Irshad / Getty Images) On Friday, Pfizer and BioNTech announced that their latest vaccine trial was showing some odd results in children within a specific age range. Children in the 2- to 5-year age group didn't produce as strong of an antibody response to the vaccine as older and younger children did.…











